Hong Kong Stock Mid-Review | Hang Seng Index rose 1.88% in the morning session, Hang Seng Biotechnology Index surged 3.77%

The Hong Kong Hang Seng Index rose 1.88% in the morning session, reporting 25,439 points, while the Hang Seng Biotechnology Index surged 3.77%. Pharmaceutical stocks collectively rose, driven by the debut of drugs listed in the "dual directory" of medical insurance. Zhonghui Biotechnology-B rose 24%, JIUYUAN GENE rose 8.99%, and KINTOR PHARMA-B rose 5.7%. Tencent's performance exceeded expectations, with Tencent Music-SW rising 15%. Chongqing Machinery and Electric Co. expects a mid-term net profit growth of about 50%. QiuTai Technology's net profit in the first half increased by 1.67 times, receiving target price upgrades from multiple institutions. 361 Degrees fell over 10% after earnings